Arvinas, Inc. (ARVN)
13.72
-0.04
(-0.29%)
USD |
NASDAQ |
Mar 05, 16:00
13.48
-0.24
(-1.75%)
Pre-Market: 08:47
Arvinas Cash from Investing (TTM) : 407.60M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Orthofix Medical, Inc. | -35.68M |
| Pfizer Inc. | -1.351B |
| Apellis Pharmaceuticals, Inc. | -0.313M |
| Elanco Animal Health, Inc. | -279.00M |
| Gossamer Bio, Inc. | 136.42M |